ClinicalTrials.gov
public full text
Public Domain
Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
Chloroquine might very well be able to increase overall survival in small cell lung cancer by sensitizing cells resistant to chemotherapy and radiotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways#716144
- AURORA: Analysing and understanding responses to oncological regimens with artificial intelligence#1149592
- Crizotinib – a tyrosine kinase inhibitor that stimulates immunogenic cell death#1146117
- SCLC TumorMiner: A Genomics Platform for Small Cell Lung Cancer Precision Oncology#238026
- Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19#253059
Record · ID 980436
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive